What's breaking now, across thousands of outlets.
Ultragenyx drug fails pivotal Phase 3, FDA's success at regulating unproven stem cells, and other biotech news
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
The FSSAI has ordered the CG Foods India factory to stop producing certain Wai Wai products due to safety violations. Inspections revealed the reuse of broken noodles and unlicensed production…
GoodRx Companion Family Plan covers a primary member and up to four members, with no age restrictions and the inclusion of pets.
LAUTECH resident doctors protest poor working conditions, unpaid wage arrears, and severe understaffing, demanding urgent intervention from the Oyo State G Read More…
An invasive mosquito species known to transmit diseases such as the dengue and Zika viruses has been found to be breeding in the UK for the first time.
AbbVie said its T cell engager etentamig cut the risk of disease progression or death by 60% compared with standard therapies in a Phase 3 multiple myeloma trial.
The failure of what was once considered a potential blockbuster therapy represents a major setback in a tough-to-treat disease and is forcing Ultragenyx to closely examine its expenses.
